• Tolremo is a biotech company developing a proprietary drug discovery and development platform to the development of cancer therapy resistance.
Translate »


Investment into sitEX Properties Holding AG, a publicly traded Swiss real estate development company with activities in Northwest Switzerland, Central Florida and Texas. Largest shareholder. Top performing publicly traded company in Switzerland with a 10-yr IRR of 19.4%.